The glucagon-like peptide-1 (GLP-1) receptor agonist,...

  • Main
  • 2015 / 10
  • The glucagon-like peptide-1 (GLP-1) receptor agonist,...

The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomised controlled trial.

Thazhath, Sony S., Marathe, Chinmay S., Wu, Tongzhi, Chang, Jessica, Khoo, Joan, Kuo, Paul, Checklin, Helen L., Bound, Michelle J., Rigda, Rachael S., Crouch, Benjamin, Jones, Karen L., Horowitz, Mich
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes
DOI:
10.2337/db15-0893
Date:
October, 2015
File:
PDF, 537 KB
english, 2015
Conversion to is in progress
Conversion to is failed